Nilufer Ertekin-Taner, MD, PhD

  • 6155 Citations
  • 37 Scopus h-Index
19962020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Keywords

  • Q Science (General)
  • Alzheimer's disease
  • Neurodegenerative diseases
  • genetics
  • genomics
  • transcriptome
  • gene expression
  • epigenetics
  • dementia

Fingerprint Dive into the research topics where Nilufer Ertekin-Taner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

Alzheimer's Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways

Zhao, N., Ren, Y., Yamazaki, Y., Qiao, W., Li, F., Felton, L. M., Mahmoudiandehkordi, S., Kueider-Paisley, A., Sonoustoun, B., Arnold, M., Shue, F., Zheng, J., Attrebi, O. N., Martens, Y. A., Li, Z., Bastea, L., Meneses, A. D., Chen, K., Thompson, J. W., St John-Williams, L. & 12 others, Tachibana, M., Aikawa, T., Oue, H., Job, L., Yamazaki, A., Liu, C. C., Storz, P., Asmann, Y. W., Ertekin-Taner, N., Kanekiyo, T., Kaddurah-Daouk, R. & Bu, G., Jan 1 2020, (Accepted/In press) In : Neuron.

Research output: Contribution to journalArticle

  • Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

    EADB (Alzheimer Disease European DNA biobank), IFGC (International FTD-Genomics Consortium), IPDGC (The International Parkinson Disease Genomics Consortium), RiMod-FTD (Risk and Modifying factors in Fronto-Temporal Dementia), Netherlands Brain Bank (NBB), The GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group & DESGESCO (Dementia Genetics Spanish Consortium), May 1 2020, In : Acta neuropathologica. 139, 5, p. 959-962 4 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study

    The Alzheimer’s Disease Genetics Consortium, Dec 1 2020, In : Nature communications. 11, 1, 667.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Scopus citations

    Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation

    Johnson, E. C. B., Dammer, E. B., Duong, D. M., Ping, L., Zhou, M., Yin, L., Higginbotham, L. A., Guajardo, A., White, B., Troncoso, J. C., Thambisetty, M., Montine, T. J., Lee, E. B., Trojanowski, J. Q., Beach, T. G., Reiman, E. M., Haroutunian, V., Wang, M., Schadt, E., Zhang, B. & 13 others, Dickson, D. W., Ertekin-Taner, N., Golde, T. E., Petyuk, V. A., De Jager, P. L., Bennett, D. A., Wingo, T. S., Rangaraju, S., Hajjar, I., Shulman, J. M., Lah, J. J., Levey, A. I. & Seyfried, N. T., May 1 2020, In : Nature Medicine. 26, 5, p. 769-780 12 p.

    Research output: Contribution to journalArticle

  • 4 Scopus citations

    Longitudinal amyloid-β PET in atypical Alzheimer's disease and frontotemporal lobar degeneration

    Whitwell, J. L., Tosakulwong, N., Weigand, S. D., Graff-Radford, J., Duffy, J. R., Clark, H. M., Machulda, M. M., Botha, H., Utianski, R. L., Schwarz, C. G., Senjem, M. L., Strand, E., Ertekin-Taner, N., Jack, C. R., Lowe, V. J. & Josephs, K. A., Jan 1 2020, In : Journal of Alzheimer's Disease. 74, 1, p. 377-389 13 p.

    Research output: Contribution to journalArticle